SCS-0140169-6/11/1

Lilly del Caribe, Inc. — FEI 3004525072

Refusal Details

Date
May 13, 2020
Country
United States
Product Category
Drugs and Biologics
Product Code
66SCA51 TADALAFIL
Charges
75